Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
And in a report in the Los Angeles Times “Booster Shots” blog, “Men who are infected with the sexually transmitted bacterium Trichomonas vaginalis have a slightly increased risk of developing prostate cancer and double the normal risk of developing the aggressive form of the disease that spreads throughout the body.”
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: risk, serum, T. vaginalis | Leave a Comment »
On Tuesday this week we reported on a study suggesting that some prostate cancers might be caused by the XMRV virus. Now comes a study suggesting that specific types of stems cells may be implicated in the development of some prostate cancers.
Filed under: Prevention | Tagged: cause, origin, stem cells | Leave a Comment »
Skip Lockwood of ZERO — The Project to End Prostate Cancer has today provided an update on the many prostate cancer issues that the US Congress has been and will be working on as the fiscal year and the 2009 legislative cycle draw to a close.
Filed under: Uncategorized | Tagged: policy update, ZERO | Leave a Comment »
If I was the VP of marketing for Intuitive Surgical — the makers of the da Vinci surgical “robot” — I would probably have done what the company has just done, which is to partner with a national cancer organization to promote prostate cancer awareness while linking such awareness closely to awareness about robot-assisted laparoscopic [...]
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: awareness, da Vinci, surgery | Leave a Comment »
It has been widely argued that three-dimensional prostate mapping biopsies (3D-PMB) are necessary and more appropriate than traditional transrectal ultrasound (TRUS) biopsies in the assessment and staging of certain types of patient, most particularly those who are considering some form of focal therapy (e.g., cryotherapy or high-intensity focused ultrasound) to only one lobe of the [...]
Filed under: Diagnosis, Risk | Tagged: biopsy, mapping | 6 Comments »
Many readers might be interesting in listening to (or reading the transcript of) a discussion between Ira Flatow of National Public Radio and Dr. Martin Sanda of Harvard University that was broadcast on the program “Science Friday” on September 4th.
Filed under: Diagnosis, Management, Risk, Uncategorized | Tagged: active surveillance, Diagnosis, expectant management, risk, watchful waiting | Leave a Comment »
There have been frequent suggestions over the years that specific viruses may be implicated in the development of certain types of cancer, and an article in this week’s Proceedings of the National Academy of Science discusses the possibility that this may be the case in aggressive forms of prostate cancer.
Filed under: Diagnosis, Risk | Tagged: aggressive, virus, XMVR | Leave a Comment »
Every so often, we come across articles that offer a “teaching opportunity” for the laymen. Such articles are often associated with what feels like over-interpretation by scientists of the results of their research.
Filed under: Diagnosis, Risk | Tagged: risk, screening | 1 Comment »
One of the issues that worries people about active surveillance and other forms of “non-interventional” management for prostate cancer is whether patients will suffer unduly from anxiety and distress while living with “untreated” cancer. We know that there are patients who have been on such protocols long-term who do not; we also know that there [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, anxiety, depression, distress | 6 Comments »
Today’s news reports contain items on: Racial disparities in 10-year survival, even in specialized clinical trials Sunitinib + docetaxel in treatment of CRPC Docetaxel + ABT-751 in treatment of CRPC
Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: ABT-751, docetaxel, racial disparities, sunitinib, survival | Leave a Comment »
We are pleased to see that President Obama has officially declared September 2009 as Prostate Cancer Awareness Month here in the USA.
Filed under: Living with Prostate Cancer | Tagged: awareness month, Obama | 2 Comments »
For 15 to 20 years, some among the prostate cancer community (including the current author) have continuously argued that some form of careful patient monitoring (call it watchful waiting; call it active surveillance; call it what you will) is a better management option than aggressive and invasive treatment for carefully identified patients believed to have [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, localized, risk, Treatment | 3 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site